Zargis Receives Additional Contracts from U.S. Army
10 October 2008 - 12:00AM
PR Newswire (US)
PRINCETON, N.J., Oct. 9 /PRNewswire/ -- Zargis Medical Corp., a
spin-off from Siemens Corporate Research, a division of Siemens AG
(NYSE:SI), and a majority-owned subsidiary of Speedus Corp.
(NASDAQ:SPDE), today announced that it was awarded six additional
contracts from the U.S. Army totaling $270,000. Included in these
awards is $170,000 of orders for nine upgraded versions of the
telemedicine pilot-systems which Zargis delivered to the Army
earlier this year. Based on the Army's successful evaluation of the
initial prototypes in a large military hospital, they have decided
to expand the scope of the project and purchase these additional
units. The upgraded systems provide improved data collection
quality and are designed to record, synchronize and analyze heart
sounds, lung sounds, ECG signals and, in some cases, blood oxygen
saturation levels from patients being cared for by remote military
treatment facilities located throughout the Pacific Rim. The
systems will be fully integrated with an existing Army telehealth
platform. "We're very pleased by the success of the prototype
telemedicine systems delivered to the Army earlier this year,"
stated Zargis CEO John Kallassy. "The demand for medical systems
designed to remotely project the expertise of cardiologists and
other medical specialists is growing very rapidly -- within both
military and civilian environments worldwide -- and it is for this
reason that Zargis has identified the field of telemedicine as a
key focus area for commercialization of our products." About Zargis
Medical Corp. Zargis Medical Corp. develops advanced diagnostic
decision support products and services for primary care physicians,
pediatricians, cardiologists and other healthcare professionals.
Zargis was formed in 2001 when Siemens Corporate Research, a
division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to
develop and market an advanced acoustic technology designed to
detect heart abnormalities identified through analysis of heart
sounds. For additional information about Zargis or Speedus Corp.,
contact Peter Hodge at 888.773.3669 (ext. 23) or , or visit the
following Web sites: http://www.zargis.com/ and
http://www.speedus.com/. Statements contained herein that are not
historical facts, including but not limited to statements about the
Company's product, corporate identity and focus, may be
forward-looking statements that are subject to a variety of risks
and uncertainties. There are a number of important factors that
could cause actual results to differ materially from those
expressed in any forward-looking statements made by the Company,
including, but not limited to, the continuing development of the
Company's sales, marketing and support efforts. DATASOURCE: Zargis
Medical Corp. CONTACT: Peter Hodge, 888-773-3669 (ext. 23), Web
site: http://www.speedus.com/ http://www.zargis.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Speedus Corp (CE) (OTCMarkets): 0 recent articles
More Speedus (MM) News Articles